FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Top News
Detained in Myanmar
North Korea
Reuters Investigates
Tech
The Wider Image
The Road to Brexit
Syria
Sports
Commentary
Pictures
Markets News
February 6, 2018 / 8:32 AM / 3 months ago

BRIEF-India's Natco Pharma Dec-Qtr Consol Profit Rises

Reuters Staff

1 Min Read

Feb 6 (Reuters) - Natco Pharma Ltd:

* DEC QUARTER CONSOL NET PROFIT 2.18 BILLION RUPEES VERSUS PROFIT 1.95 BILLION RUPEES YEAR AGO

* RECOMMENDED DIVIDEND OF 7 RUPEES PER SHARE

* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 5.62 BILLION RUPEES VERSUS 6.79 BILLION RUPEES YEAR AGO

* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 5.62 BILLION RUPEES VERSUS 6.79 BILLION RUPEES YEAR AGO Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.